Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal intensity of anticoagulation with warfarin in Korean patients with atrial fibrillation
KCT0007994Phase 4Completed
- Sponsor
- The Korean Society of Cardiology
- Start
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of warfarin in Atrial fibrillation (AFib), sponsored by The Korean Society of Cardiology. Started Feb 2017; status: completed.
02
Drugs
warfarin
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on KCT0007994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0007994.